Search

Search Constraints

You searched for: Author/Creator Pelletier, Alex

Search Results

1. [O2–14–02]: PRECLINICAL ASSESSMENT OF KAL‐ABP TARGET ENGAGEMENT AND EFFICACY USING PET, MRI AND CSF BIOMARKERS. (1st July 2017)

2. [P2–054]: BRAIN DELIVERY OF AN AMYLOID‐β OLIGOMER (AβO)‐TARGETING PEPTIDE‐THERAPEUTIC BY A NOVEL BLOOD‐BRAIN BARRIER (BBB)‐CROSSING DOMAIN ANTIBODY. (1st July 2017)

3. Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIX. Issue 1 (1st January 2021)

4. Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX. Issue 1 (1st January 2021)

5. P1‐072: PRE‐CLINICAL CHARACTERIZATION OF HUMANIZED, BLOOD‐BRAIN BARRIER (BBB)‐PENETRATING, AMYLOID‐β (Aβ) OLIGOMER‐TARGETING FUSION PROTEIN. (1st July 2006)

6. SERS-based assay for multiplexed detection of cross-reactivity and persistence of antibodies against the spike of the native, P.1 and B.1.617.2 SARS-CoV-2 in non-hospitalised adults. Issue 4 (28th June 2022)